| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-03-31 FY | 2023-12-31 FY | 2023-03-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – |
| Operating Expenses | $4.43M | $6.05M | $833.00 | $4.12M | $757.00K | $3.67M | $2.19M |
| R&D | – | – | – | – | – | – | – |
| SG&A | $1.57M | $1.88M | $472.00K | $1.71M | $476.00K | $1.36M | $952.00K |
| Operating Income | – | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | $0.00 | – | $0.00 | $0.00 |
| Net Income | -$3.83M | -$5.37M | -$730.00K | -$3.75M | -$380.00K | -$3.93M | -$2.37M |
| EPS (basic) | – | -0.0700 | – | -0.0500 | – | – | – |
| EPS (diluted) | -0.0400 | -0.0700 | – | – | – | – | – |
| Shares (diluted) | $86.77M | $81.00M | – | – | – | – | – |